Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
27.38
+0.11 (0.40%)
At close: May 15, 2026, 4:00 PM EDT
27.15
-0.23 (-0.84%)
After-hours: May 15, 2026, 5:24 PM EDT
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $2.26 billion as of May 15, 2026. Its market cap has increased by 202.23% in one year.
Market Cap
2.26B
Enterprise Value
1.57B
1-Year Change
202.23%
Ranking
Category
Stock Price
$27.38
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $2.26B, an increase of 261.46%. That is a compound annual growth rate of 48.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 2.27B | -4.51% |
| Dec 31, 2025 | 2.38B | 287.33% |
| Dec 31, 2024 | 613.22M | 77.85% |
| Dec 29, 2023 | 344.80M | -44.82% |
| Feb 10, 2023 | 624.91M | - |
View and export this data all the way back to 2023. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nektar Therapeutics | 2.51B |
| Immunome | 2.49B |
| Relay Therapeutics | 2.45B |
| Kodiak Sciences | 2.42B |
| Definium Therapeutics | 2.33B |
| Zai Lab | 2.28B |
| Tyra Biosciences | 2.17B |
| Trevi Therapeutics | 2.14B |